Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Oral Formulations of Calcium Dobesilate Capsules in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

MLA

Wang, Yanrong, et al. “Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Oral Formulations of Calcium Dobesilate Capsules in Healthy Chinese Volunteers Under Fasting and Fed Conditions.” Clinical Pharmacology in Drug Development, vol. 13, no. 4, Apr. 2024, pp. 360–66. EBSCOhost, https://doi.org/10.1002/cpdd.1376.

APA

Wang, Y., Liu, Y., Tang, L., Gao, J., Li, H., Dai, X., Chen, R., & Wang, F. (2024). Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Oral Formulations of Calcium Dobesilate Capsules in Healthy Chinese Volunteers Under Fasting and Fed Conditions. Clinical Pharmacology in Drug Development, 13(4), 360–366. https://doi.org/10.1002/cpdd.1376

Chicago

Wang, Yanrong, Ying Liu, Liyuan Tang, Jie Gao, Hongmin Li, Xinya Dai, Ran Chen, and Fengqin Wang. 2024. “Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Oral Formulations of Calcium Dobesilate Capsules in Healthy Chinese Volunteers Under Fasting and Fed Conditions.” Clinical Pharmacology in Drug Development 13 (4): 360–66. doi:10.1002/cpdd.1376.